(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 14.81% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.89%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.61%.
Astrana Health's revenue in 2026 is $3,181,769,000.On average, 13 Wall Street analysts forecast ASTH's revenue for 2026 to be $225,361,382,694, with the lowest ASTH revenue forecast at $208,457,888,902, and the highest ASTH revenue forecast at $238,928,660,606. On average, 10 Wall Street analysts forecast ASTH's revenue for 2027 to be $249,660,155,020, with the lowest ASTH revenue forecast at $228,530,787,780, and the highest ASTH revenue forecast at $267,230,891,988.
In 2028, ASTH is forecast to generate $263,394,243,726 in revenue, with the lowest revenue forecast at $253,051,974,498 and the highest revenue forecast at $271,123,143,848.